Tianli Pharmaceutical's net profit for H1 2025 rises 32.49 % YoY

On 29 Aug., 2025, Suntar Environmental Technology Co., Ltd. (Suntar) released its 2025 interim report. In H1 2025, Shandong Tianli Pharmaceutical Co., Ltd. (Tianli Pharmaceutical), an associate of Suntar, recorded:Revenue: USD229.34 million (RMB1.63 ...

Sweeteners China News 202509

www.cnchemicals.com